How to extract cycloastragenol from astragalus​?

Cycloastragenol powder is extracted from the mature roots of Astragalus membranaceus after careful selection. Astragaloside IV is then hydrolytically cleaved by enzymatic or acid catalyzed processes, purified by column chromatography and crystallized to pharmaceutical grade purity levels. This triterpenoid saponin has generated a lot of interest in the anti-aging product industry due to its association with pathways that activate telomerase and extends the lifespan of cells. For B2B buyers, product directors and formulation managers in the nutritional supply chain, the technical details of extraction methods impact how to differentiate products, meet regulations and maximize profitability. Our factory in Xi'an, Le-Nutra Ingredients Inc. manufactures 98% cycloastragenol powder to strict international standards. "We have all the certifications and we've been pulling out this substance for ten years.

Cycloastragenol powder is an ultra-purified triterpenoid saponin derived from the roots of Astragalus membranaceus. It is different from its glycosylated precursor, astragaloside IV, because sugar groups have been removed. This molecular change makes the compounds considerably more bioavailable and easier for cells to take in than the parent compounds found in raw plant extracts. The compound is lipophilic (molecular weight of 490.7 g/mol) and can easily cross cellular membranes. This makes it very useful in formulations that are designed to rejuvenate cells and improve metabolic health.

Astragalus membranaceus, commonly known as Huang Qi, is mainly grown in northern China, Mongolia and Korea in traditional systems. Roots have a period of 4 – 7 years to reach the desired level of saponin concentration. The plant contains large quantities of bioactive substances, including polysaccharides, flavonoids, and a complex saponin fraction . Astragaloside IV constitutes between 0.2% and 2.0% of the dry weight, depending on species and harvest time. Cycloastragenol is naturally present in very small concentrations, generally less than 0.01%. It is changed by chemicals or enzymes so that it can be sold. Geographic origin strongly influences saponin profiles. In general, the roots of high-altitude plants contain more active compounds and conscientious vendors verify this through certificates of origin and phytochemical fingerprinting.

Smaller producers still use traditional extraction methods like hot water decoction, ethanol maceration, and simple solvent extraction, but these methods make it hard for brands that need pharmaceutical-grade consistency. When you use these methods, you usually end up with crude Astragalus root extracts that have 10–20% total saponins and very little cycloastragenol. The different types of these extracts make standardization harder because the chemical ratios change from batch to batch, which makes formulations unstable and makes it hard to predict how bioavailable finished goods will be.

Usually, ethanol or methanol is used for solvent extraction at room temperature and for long maceration times (48 to 72 hours). This leads to incomplete chemical extraction and the removal of useless parts like starches, proteins, and tannins. Target saponin yield rates rarely go above 1.5% to 2% of the weight of the raw material. For cycloastragenol, the recovery rate is even lower because it is so rare in nature. Even worse, changes in the quality of the raw materials that happen with the seasons, the ratios of solvents that don't always work, and changes in temperature during processing all cause batch differences that make it impossible to reliably standardize the product. For B2B clients who make high-end anti-aging supplements, this variation creates an unacceptable risk-analytical testing may show purity ranging from 40–75% across batches, which makes label claims harder to understand and could lead to regulatory scrutiny when finished products are checked by a third party.

Modern methods for making cycloastragenol powder use multiple steps that combine advanced extraction technologies with chemical or enzymatic conversion steps. This makes the process much more efficient, pure, and good for the environment than older methods. With these methods, you can precisely control parameters like temperature, pressure, pH, and reaction time, all while keeping the purity of the substance and meeting pharmaceutical-grade standards.

Supercritical CO2 Extraction for Initial Saponin Concentration

When CO2 is used for supercritical fluid extraction, it works above the critical point (31.1°C, 73.8 bar), where the fluid has the ability to penetrate like a gas and dissolve like a liquid. This method selectively removes polar impurities like polysaccharides and proteins while leaving behind lipophilic saponins. This leaves a concentrated saponin fraction (40–60% purity) from raw Astragalus root. You can change the process settings, especially the pressure (200–350 bar) and the amount of co-solvent added (5–10% ethanol), to get the most astragaloside IV and the least amount of breakdown. There are several big benefits to supercritical CO2 extraction. First, it completely removes the solvent through simple depressurization, so there are no worries about residual solvents. Second, it works at moderate temperatures (35–50°C), which keeps sensitive triterpenoids from breaking down; and third, the closed-loop system recycles CO2, which is better for the environment. Our facility uses a 500L supercritical extraction system with controlled pressure cycling to process 200 kg of raw material per batch and recover 85% of the saponin, which sets the stage for the next steps of purification.

Enzymatic and Acid Hydrolysis for Cycloastragenol Conversion

To change astragaloside IV into cycloastragenol, specific glycosidic links that connect glucose groups to the aglycone structure need to be cut. There are two main ways that business output is done. β-glucosidases or cellulases are used in enzymatic hydrolysis at a fixed pH (4.5–6.0) and temperature (45–55°C) for 24–48 hours. This method has a high selectivity and few side effects; conversion rates usually reach 75–85% with enzyme loadings of 2–5% w/w relative to substrate. Using weak mineral acids (HCl or H2SO4, 0.5-2.0 M) at high temperatures (80–100°C) for 2–8 hours speeds up the process (6–12 hours), but it creates more impurities that need to be cleaned up in a lot of steps later on. In our production process, we use enzymes to get rid of the last few glucose units, then mild acid catalysis to make the final aglycones. This balances the efficiency of the conversion with the quality of the product. After the reaction mixture is neutralized, ethyl acetate is used for liquid-liquid extraction to separate cycloastragenol from water-based impurities. This concentrates the target chemical for chromatographic processing.

Chromatographic Purification and Crystallization

To get 98% purity, you need to use chromatographic separation with macroporous resin columns or preparative HPLC systems. Using macroporous resin chromatography with resins like AB-8 or D101 separates compounds based on how hydrophobic they are. Cycloastragenol, which is relatively lipophilic after deglycosylation, binds strongly and elutes with 70–90% ethanol gradients, separating from astragalosides and degradation products that are still present. The column settings (height of the resin bed, flow rate, and sample loading) are tweaked using the design of experiments method to get the best clarity and throughput at the same time. The enriched fraction is concentrated in a vacuum at 40–50°C to keep it from breaking down at higher temperatures. This is followed by crystallization from mixtures of ethanol and water. Crystallization does two things: it makes the substance even purer through selective nucleation, and it also makes a steady, free-flowing powder with a clear particle size distribution. Our facility uses a seven-step purification process that includes initial resin chromatography, secondary silica gel separation, activated carbon decolorization, and controlled crystallization. This process consistently makes white to off-white cycloastragenol powder that meets USP monograph specifications when available and goes beyond industry purity standards.

To get pharmaceutical-grade cycloastragenol powder from Astragalus membranaceus, you have to go through a complex process with several steps that includes advanced extraction technologies, precise hydrolytic conversion, and strict chromatographic purification. When looking for suppliers for high-end anti-aging supplements, brand owners need to look at more than just the suppliers' purity standards and certifications. They also need to look at the suppliers' production capacity, batch uniformity, legal support, and partnership approach to product development. This guide gives procurement workers the technical information they need to ask good questions, understand analytical documents, and tell the difference between real quality sellers and commodity traders. Supply chain decisions made today will have long-lasting effects on product performance, regulatory compliance, and brand image in the years to come. This is why choosing a seller is one of the most important strategic decisions anti-aging supplement brands have to make.

What extraction solvent produces the safest and most effective cycloastragenol?

The best combination of safety and effectiveness is supercritical CO2 extraction followed by purification steps using food-grade ethanol. CO2 doesn't leave behind any harmful chemicals and works at normal temperatures, which protects the integrity of compounds. On the other hand, ethanol is GRAS and can be completely removed through vacuum distillation, which makes sure it meets all regulations in major markets like the US, EU, and Asia-Pacific.

How can I verify cycloastragenol powder purity and authenticity before large orders?

Ask for full analytical reports that include HPLC chromatograms with data on single-peak purity and retention time, mass spectrometry results that confirm the molecular weight (490.7 g/mol), and NMR results that confirm the structure. Reliable suppliers, such as Xi'an Le-Nutra Ingredients Inc., offer third-party lab confirmation from approved facilities and small sample sizes (10–50g) for independent testing before making business commitments.

What are typical MOQ and lead times for bulk cycloastragenol orders?

For business production, the standard MOQ is between 10 and 25 kg, and sample amounts (1 to 5 kg) can be used for suitability testing. For in-stock items, lead times are two to three weeks, and for custom orders, they are four to six weeks. Our facility keeps safety stock so that urgent orders can be delivered in 7–10 days. This helps brands that are looking to take advantage of quick market opportunities or deal with supply problems from their current suppliers.

Source Premium 98% Cycloastragenol Powder from an Established Manufacturer

Xi'an Le-Nutra Ingredients Inc. makes pharmaceutical-grade cycloastragenol powder that is always 98% pure and has ISO 22000, cGMP, Halal, Kosher, and Non-GMO certifications to back it up. Our 60,000㎡ factory has six multifunctional production lines that can make up to 3,000 tons of goods every year. This makes sure that growing brands and big makers have a steady supply. We offer full technical paperwork (COA, TDS, and allergy statements) to help with regulatory compliance in the US, Europe, and the Asia-Pacific region. In addition to providing raw materials, our R&D team can help you turn your product ideas into anti-aging vitamins that are ready for the market through recipe development, private label manufacturing, and custom extraction. You can email our team at info@lenutra.com to get free samples, technical information, and bulk pricing on the astragalus root extract we sell. Visit lenutra.com to see our full list of anti-aging ingredients and find out how our 14+ years of experience extracting plants can speed up the development of your product while maintaining the highest quality standards.

References

Chen, L.X., Zhao, J., Yang, F., & Liu, R.H. (2019). "Structural elucidation and bioactivity evaluation of saponins from Astragalus membranaceus roots." Journal of Pharmaceutical and Biomedical Analysis, 168, 47-58.

Harley, C.B., Liu, W., & Blasco, M. (2011). "A natural product telomerase activator as part of a health maintenance program." Rejuvenation Research, 14(1), 45-56.

Kim, Y.J., Kwon, H.C., & Ko, H. (2018). "Comparison of extraction methods for cycloastragenol from Astragalus roots: Yield, purity, and biological activity." Separation and Purification Technology, 195, 238-247.

Li, M., Wang, W., Xue, J., Gu, Y., & Lin, S. (2020). "Advanced chromatographic techniques for purification of triterpenoid saponins from medicinal plants." Journal of Chromatography A, 1609, 460457.

United States Pharmacopeia. (2021). "General Chapter <232> Elemental Impurities-Limits and <233> Elemental Impurities-Procedures." USP 44-NF 39.

Zhang, P., Liu, X., Zhu, Y., Chen, S., & Zhou, D. (2017). "Optimization of supercritical fluid extraction and enzymatic hydrolysis for production of cycloastragenol from Astragalus membranaceus." Industrial Crops and Products, 108, 241-250.